Friday, November 22, 2024
HomeTagsPhase I Study

Phase I Study

Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that its novel...

Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 in Patients

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other...

Antengene Announces IND Approval in China for the Phase I Study of ATG-101 for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma

Antengene Corporation Limited, a leading innovative commercial stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics